Business Insights
  • Home
  • Crypto
  • Finance Expert
  • Business
  • Invest News
  • Investing
  • Trading
  • Forex
  • Videos
  • Economy
  • Tech
  • Contact

Archives

  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • August 2023
  • January 2023
  • December 2021
  • July 2021
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019

Categories

  • Business
  • Crypto
  • Economy
  • Finance Expert
  • Forex
  • Invest News
  • Investing
  • Tech
  • Trading
  • Uncategorized
  • Videos
Apply Loan
Money Visa
Advertise Us
Money Visa
  • Home
  • Crypto
  • Finance Expert
  • Business
  • Invest News
  • Investing
  • Trading
  • Forex
  • Videos
  • Economy
  • Tech
  • Contact
Is UnitedHealth Stock a Buy, Sell, or Hold for July 2025?
  • Business

Is UnitedHealth Stock a Buy, Sell, or Hold for July 2025?

  • July 3, 2025
  • Roubens Andy King
Total
0
Shares
0
0
0
Total
0
Shares
Share 0
Tweet 0
Pin it 0
Unitedhealth Group Inc phone and site-by T_Schneider via Shutterstock

UnitedHealth (UNH) has found itself under a harsh spotlight on Wall Street. Once a darling of defensive investors, UNH stock has been battered and bruised in 2025, tumbling nearly 40% year-to-date (YTD). Among S&P 500 Index ($SPX) constituents, it now ranks among the poorest performers, a dramatic shift for a company long considered a fortress in health insurance.

The trouble began with a disappointing earnings report earlier this year, which sparked fears of mounting costs and operational inefficiencies. Then came the one-two punch: UnitedHealth withdrew its forward guidance and announced a CEO shake-up. As if that were not enough, the U.S. Department of Justice reportedly began probing its billing practices, raising further red flags.

Right now, the question is no longer “what went wrong” but whether there is a light at the end of the tunnel. Some investors, contrarian by nature, argue that much of the damage has already been priced in. If these headwinds prove temporary, this bruised blue chip could offer a rare opportunity.

Headquartered in Minnesota, UnitedHealth is one of the most influential players in the U.S. healthcare system. The company operates a suite of offerings including health maintenance organizations, preferred provider organizations, point-of-service plans, and managed fee-for-service programs.

As of now, UnitedHealth commands a market capitalization of $280 billion. However, its stock performance has been anything but steady. In the past three months alone, UNH has slipped 40%. From its 52-week high of $630.73, the drop extends to 50%, a fall that has rattled long-time shareholders.

www.barchart.com
www.barchart.com

Yet, beneath this decline lies a potential value proposition. Currently, UNH trades at 13.7 times forward adjusted earnings and just 0.69 times sales, Both of these valuation metrics sit well below their five-year historical averages, indicating potential upside for those willing to bet on a turnaround.

Adding to its appeal, UnitedHealth pays an annualized forward dividend of $8.51, offering a 2.75% yield. The company has also raised its dividend for 15 consecutive years. Its most recent quarterly dividend of $2.21 was paid on June 24 to shareholders who held the stock as of June 16.

On April 17, UnitedHealth reported its fiscal 2025 first-quarter earnings. The results left much to be desired. While revenue increased to $109.6 billion, growing 9.8% year-over-year (YOY), it fell short of Wall Street’s forecast of $111.13 billion. On the bottom line, adjusted EPS grew 4.2% from the prior year’s quarter to $7.20 but missed the expected $7.27 per share.

Diving deeper, earnings from operations rose to $9.1 billion, climbing 15% from a year earlier, while adjusted net earnings improved 3% to $6.6 billion. As of March 31, UnitedHealth held $34.3 billion in cash and short-term investments, up from $29.1 billion at the close of 2024.

But not all is smooth sailing. The company continues to wrestle with higher-than-anticipated cost pressures and spikes in utilization, especially within its Medicare Advantage segment. While these challenges have clearly unsettled the market, management remains resolute.

CEO Stephen Hemsley acknowledged that both external market forces and internal oversights played a role in the stumble. However, the CEO emphasized that the majority of issues are within the company’s power to correct. As part of its long-term strategy, UnitedHealth continues to focus on modernization and innovation, aiming to achieve earnings growth between 13% and 16% in the coming years.

The next key moment will arrive on Tuesday, July 29, when UnitedHealth announces its Q2 results before the market opens. Analysts forecast Q2 2025 EPS to fall 25% YOY to $5.08, while full fiscal year 2025 EPS is projected to decline 20% to $22.07. For fiscal 2026, EPS is expected to rebound by 15% to $25.39.

Despite a rough start to 2025, analysts have not entirely soured on UnitedHealth. The stock currently carries a “Moderate Buy” consensus rating, suggesting that the Street sees light at the end of the tunnel.

Out of the 24 analysts covering UNH stock, 15 have a “Strong Buy,” two rate it as a “Moderate Buy,” and seven recommend a “Hold” for the stock for now. The average price target of $363.43 represents potential upside of 16%. Meanwhile, the Street-High target of $440 suggests a potential climb of 41% from current levels.

That said, patience remains a critical factor here. Analysts appear cautiously optimistic, holding onto belief in the company’s underlying fundamentals but staying wary of near-term volatility.

www.barchart.com
www.barchart.com

On the date of publication, Aanchal Sugandh did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. This article was originally published on Barchart.com

Total
0
Shares
Share 0
Tweet 0
Pin it 0
Roubens Andy King

Previous Article
This is the Best Way to Spot Red Flags During Your Tenant Screening
  • Invest News

This is the Best Way to Spot Red Flags During Your Tenant Screening

  • July 3, 2025
  • Roubens Andy King
Read More
Next Article
Stocks climb to record, gilt yields surge on finance minister uncertainty
  • Finance Expert

Stocks climb to record, gilt yields surge on finance minister uncertainty

  • July 3, 2025
  • Roubens Andy King
Read More
You May Also Like
Walmart+ adds Peacock to streaming offerings to better compete with Amazon Prime
Read More
  • Business

Walmart+ adds Peacock to streaming offerings to better compete with Amazon Prime

  • Roubens Andy King
  • September 3, 2025
Weak pound and yen shore up dollar, bonds and payrolls in focus
Read More
  • Business

Weak pound and yen shore up dollar, bonds and payrolls in focus

  • Roubens Andy King
  • September 3, 2025
Salesforce CEO Marc Benioff says he cut 4,000 support roles because of AI
Read More
  • Business

Salesforce CEO Marc Benioff says he cut 4,000 support roles because of AI

  • Roubens Andy King
  • September 2, 2025
Let’s Break Down What You Need to Be Watching This Week
Read More
  • Business

Let’s Break Down What You Need to Be Watching This Week

  • Roubens Andy King
  • September 2, 2025
Google won’t be forced to sell its Chrome browser, judge rules
Read More
  • Business

Google won’t be forced to sell its Chrome browser, judge rules

  • Roubens Andy King
  • September 2, 2025
Gold price hits record high as investors seek safe haven | Gold
Read More
  • Business

Gold price hits record high as investors seek safe haven | Gold

  • Roubens Andy King
  • September 2, 2025
How Is Chevron’s Stock Performance Compared to Other Oil & Gas Exploration & Production Stocks?
Read More
  • Business

How Is Chevron’s Stock Performance Compared to Other Oil & Gas Exploration & Production Stocks?

  • Roubens Andy King
  • September 2, 2025
Bunker Hill tower One California Plaza goes into receivership
Read More
  • Business

Bunker Hill tower One California Plaza goes into receivership

  • Roubens Andy King
  • September 2, 2025

Recent Posts

  • Excelsoft Technologies IPO Review
  • Federal Reserve Board – Minutes of the Federal Open Market Committee, January 27–28, 2026
  • 10 Legendary Figures Who Gained Fame Posthumously
  • Everything you should know about US investment from India | Detailed guide for US investment
  • best manufacturing business idea in India small budget business idea in India crockery wholesal
Featured Posts
  • Excelsoft Technologies IPO Review 1
    Excelsoft Technologies IPO Review
    • February 18, 2026
  • Federal Reserve Board – Minutes of the Federal Open Market Committee, January 27–28, 2026 2
    Federal Reserve Board – Minutes of the Federal Open Market Committee, January 27–28, 2026
    • February 18, 2026
  • 10 Legendary Figures Who Gained Fame Posthumously 3
    10 Legendary Figures Who Gained Fame Posthumously
    • February 18, 2026
  • Everything you should know about US investment from India | Detailed guide for US investment 4
    Everything you should know about US investment from India | Detailed guide for US investment
    • February 17, 2026
  • best manufacturing business idea in India small budget business idea in India crockery wholesal 5
    best manufacturing business idea in India small budget business idea in India crockery wholesal
    • February 16, 2026
Recent Posts
  • The New Rules of Building Wealth | Bullish
    The New Rules of Building Wealth | Bullish
    • February 15, 2026
  • If I Were To Invest 5 Lacs in Quality Stocks For LONG TERM (2030) (Ft Saurabh Mukherjea/Rahul Jain)
    If I Were To Invest 5 Lacs in Quality Stocks For LONG TERM (2030) (Ft Saurabh Mukherjea/Rahul Jain)
    • February 14, 2026
  • ‘Out of Funds.’ The Van Der Beek GoFundMe Hit .5M. Commenters Point to the .76M Ranch Bought About a Month Before His Death
    ‘Out of Funds.’ The Van Der Beek GoFundMe Hit $2.5M. Commenters Point to the $4.76M Ranch Bought About a Month Before His Death
    • February 14, 2026
Categories
  • Business (2,057)
  • Crypto (2,023)
  • Economy (215)
  • Finance Expert (1,687)
  • Forex (2,016)
  • Invest News (2,436)
  • Investing (2,040)
  • Tech (2,056)
  • Trading (2,024)
  • Uncategorized (2)
  • Videos (976)

Subscribe

Subscribe now to our newsletter

Money Visa
  • Privacy Policy
  • DMCA
  • Terms of Use
Money & Invest Advices

Input your search keywords and press Enter.